// App-Quantinova.ai

BS34 : SD-208 reverts hypertrophic cardiomyopathy myofibroblasts into fibroblasts and affects small extracellular vesicle secretion

Researchers

Presenter

  • Georgie Thompson

Principal Investigators

  • Patrizia Camelliti

  • John McVey

  • Sean M Davidson

  • Elias Sulaiman

  • Konstantinos Savvatis

  • Aled Clayton

Medical Centers

  • University of Surrey, Stag Hill University Campus Guildford, SRY GU XH United Kingdom, UK

  • Hatter Cardiovascular Institute, UCL

  • Barts Heart Centre

  • University College London

  • Cardiff University

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Hypertrophic cardiomyopathy

Biomarkers

  • Periostin

  • Interleukin 6

  • Transforming growth factor beta

  • Smooth muscle alpha-actin

Drug/Treatment

  • SD-208

  • IL-11

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved